documents: FDA-2017-D-6535-0013
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2017-D-6535-0013 | FDA | FDA-2017-D-6535 | Reference 4 - Federal Register Notice International Harmonization; Policy on Standards RE: Standards Development and the Use of Standards in Regulatory Submissions Reviewed in the Center for Biologics Evaluation and Research Guidance for Industry | Supporting & Related Material | Background Material | 2019-03-26T04:00:00Z | 2019 | 3 | 2019-03-26T15:32:08Z | 0 | 0 | 0900006483b2f6b6 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref